标题
Drug development: longer-lived proteins
作者
关键词
-
出版物
CHEMICAL SOCIETY REVIEWS
Volume 41, Issue 7, Pages 2686
出版商
Royal Society of Chemistry (RSC)
发表日期
2012-02-07
DOI
10.1039/c2cs15289d
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
- (2011) Felix F. Schumacher et al. BIOCONJUGATE CHEMISTRY
- Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
- (2011) Sang Taek Jung et al. CURRENT OPINION IN BIOTECHNOLOGY
- Immunogenicity of biotherapeutics in the context of developing biosimilars and biobetters
- (2011) Maria D.F.S. Barbosa DRUG DISCOVERY TODAY
- FDA-approved poly(ethylene glycol)–protein conjugate drugs
- (2011) Steevens N. S. Alconcel et al. Polymer Chemistry
- Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
- (2011) J. R. Cantor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
- (2010) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- In Situ Growth of Side-Chain PEG Polymers from Functionalized Human Growth Hormone—A New Technique for Preparation of Enhanced Protein−Polymer Conjugates
- (2010) Johannes Pall Magnusson et al. BIOCONJUGATE CHEMISTRY
- A Therapeutic Anti-VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- (2010) Y. A. Yeung et al. CANCER RESEARCH
- Once-Weekly GLP-1 Agonists: How Do They Differ from Exenatide and Liraglutide?
- (2010) Mikkel Christensen et al. Current Diabetes Reports
- Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3
- (2010) David R. Nelson et al. GASTROENTEROLOGY
- T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes
- (2010) Hiroyuki Koide et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Albumin fusion of thioredoxin — The production and evaluation of its biological activity for potential therapeutic applications
- (2010) Shotaro Ikuta et al. JOURNAL OF CONTROLLED RELEASE
- Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
- (2010) Takuo Suzuki et al. JOURNAL OF IMMUNOLOGY
- Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
- (2010) Satish Kumar Singh JOURNAL OF PHARMACEUTICAL SCIENCES
- Charge variants in IgG1
- (2010) Leslie A. Khawli et al. mAbs
- Improving Protein Pharmacokinetics by Engineering Erythrocyte Affinity
- (2010) Stephan Kontos et al. MOLECULAR PHARMACEUTICS
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- What's fueling the biotech engine—2009–2010
- (2010) Saurabh Aggarwal NATURE BIOTECHNOLOGY
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
- (2010) Darius Ghaderi et al. NATURE BIOTECHNOLOGY
- The safety and side effects of monoclonal antibodies
- (2010) Trevor T. Hansel et al. NATURE REVIEWS DRUG DISCOVERY
- Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose
- (2010) Nathan C. Geething et al. PLoS One
- In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation
- (2010) W. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon
- (2010) A. Walker et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein
- (2010) J. Hopp et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
- (2010) Wendy S. Putnam et al. TRENDS IN BIOTECHNOLOGY
- PEG conjugates in clinical development or use as anticancer agents: An overview
- (2009) Gianfranco Pasut et al. ADVANCED DRUG DELIVERY REVIEWS
- Fc-Based Cytokines
- (2009) Jalal A Jazayeri et al. BIODRUGS
- Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology
- (2009) Chichi Huang CURRENT OPINION IN BIOTECHNOLOGY
- Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
- (2009) M. A. Bush et al. DIABETES OBESITY & METABOLISM
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- (2009) Y. A. Yeung et al. JOURNAL OF IMMUNOLOGY
- A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
- (2009) Volker Schellenberger et al. NATURE BIOTECHNOLOGY
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Immunological Risk of Injectable Drug Delivery Systems
- (2009) Wim Jiskoot et al. PHARMACEUTICAL RESEARCH
- In situ growth of a stoichiometric PEG-like conjugate at a protein's N-terminus with significantly improved pharmacokinetics
- (2009) W. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Production and characterization of long-acting recombinant human albumin–EPO fusion protein expressed in CHO cell
- (2009) Chan-Hi Joung et al. PROTEIN EXPRESSION AND PURIFICATION
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
- (2008) C.Simone Fishburn JOURNAL OF PHARMACEUTICAL SCIENCES
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
- (2008) L. J. Holt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started